Dr. Gordan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Florida Cancer Specialists (GCC)
6420 W Newberry Rd, East Wing, Suite 100
Gainesville, FL 32605Phone+1 352-332-3900Fax+1 352-332-5009- Is this information wrong?
Summary
- Dr. Lucio Gordan is an oncologist in Gainesville, FL and is affiliated with North Florida Regional Medical Center. He received his medical degree from Other and has been in practice 24 years. He specializes in hematologic oncology and is experienced in hematologic oncology and general / benign hematology.
Education & Training
- University of FloridaFellowship, Hematology and Medical Oncology, 2000
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1994 - 1997
- OtherClass of 1994
Certifications & Licensure
- TX State Medical License 2019 - 2026
- UT State Medical License 2018 - 2026
- IL State Medical License 2018 - 2026
- FL State Medical License 1997 - 2025
- AZ State Medical License 2018 - 2023
- NC State Medical License 2018 - 2023
- OH State Medical License 2018 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Clinical Trials
- Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy Start of enrollment: 2006 Feb 01
- Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy Start of enrollment: 2006 Jan 01
Publications & Presentations
PubMed
- Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.Ray, D., Ijioma, S., Dranitsaris, G., Warner, A., Heritage, T., Chadwick, P., Khrystolubova, N., Peles, S., Gordan, L., Fink, M., Wenk, D.> ;Current Oncology. 2024 Jan 14
- 1 citationsProgression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnos...Lucio Navarro Gordan, Carlyn Rose Tan, Robert Vescio, Jing Christine Ye, Carolina Schinke, Rohan Medhekar, Alex Z Fu, Marie-Hélène Lafeuille, Philippe Thompson-Leduc, ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Jan 1
- 4 citationsCompromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of...Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois, Luca Quagliata, Lauren L Ritterhouse, Federico Cappuzzo, Brandon Wang, Mei X...> ;JCO Oncology Practice. 2024 Jan 1
- Join now to see all
Press Mentions
- Florida Cancer Specialists & Research Institute President & Managing Physician Lucio Gordan, MD Featured Speaker at Nationwide Oncology EventMay 4th, 2023
- ASCO Guideline Update for Anxiety and Depression ReleasedApril 27th, 2023
- Richard McDonough, MD Honored for Patient Advocacy Efforts, Receives Dorothy Green Phillips Legacy Award at FLASCO Annual GalaApril 20th, 2023
- Join now to see all
Professional Memberships
- Member
Other Languages
- Portuguese, Spanish
Hospital Affiliations
- HCA Florida North Florida HospitalGainesville, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: